WASHINGTON — Fall means it’s time for just about everybody to get up to date on their flu and COVID-19 vaccines – and a lot of older adults also need protection against another risky winter virus, RSV. Yes, you can get your flu and COVID-19 shots at the same time. Don’t call them boosters — … Read more
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022. Hannah Mckay | Reuters The Food and Drug Administration on Friday expanded the approval of GSK‘s respiratory syncytial virus vaccine to adults ages 50 to 59 who are at increased risk of getting severely sick from the potentially lethal virus. The shot, called Arexvy, … Read more
NEW YORK — Reports of a rare nervous system disorder were “more common than expected” in older U.S. adults who got the new RSV vaccines, according to a Centers for Disease Control and Prevention report released Thursday that’s similar to what the organization said earlier this year. Government officials still say the benefits of the … Read more
By Nicole Ireland The Canadian Press Posted May 17, 2024 4:26 pm 1 min read Descrease article font size Increase article font size The National Advisory Committee on Immunization is recommending a universal immunization program against respiratory syncytial virus, or RSV, for all infants. It says provinces and territories should work toward providing the antibody … Read more
Respiratory syncytial virus – viral vaccine under research Hailshadow | Istock | Getty Images A vaccine from Pfizer showed the potential to protect adults ages 18 to 59 who are at increased risk of getting severely sick from respiratory syncytial virus in a late stage clinical trial, the company said Tuesday. The initial data suggests … Read more
NEW YORK — Wastewater testing does a good job at detecting mpox infections, U.S. health officials said in a report Thursday that bolsters a push to use sewage to track more diseases. U.S. Centers for Disease Control and Prevention researchers found that over the course of a week, there was a 32% likelihood the tests … Read more
Descrease article font size Increase article font size Health Canada on Thursday approved another respiratory syncytial virus (RSV) vaccine for adults over the age of 60 and pregnant people. Pfizer’s bivalent RSV vaccine, Abrysvo, has been authorized for the use of pregnant individuals from 32 through 36 weeks gestational age for the prevention of lower respiratory … Read more
